Skip to content

MADANESTHESIE

Active
Private limited companyfounded 2025active for 1 yearAuguste Reyerslaan 122, 1030 Schaarbeek, BelgiumKBO/BCE: BE 1022.667.040
Summary

MADANESTHESIE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €155,760 and a net result of €152,760. Its solvency ranks better than 67% of 20,558 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
MADANESTHESIEActiveChecked score 88/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€200,760total assets 2025
Equity
€155,760
Profit
€152,760
Turnover not published (micro format)
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Accounts on time
Why 88raises riskLiquidity: current ratio 2.06, cash €1,062Founded in 2025Size: total assets €200,760lowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 58% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 100
equity 77.6% of total assets
Liquidity 43
short-term debt 22.4% · cash 0.5%
Profitability 100
return on assets 76.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,109 companies, NACE 86, micro)
Last 24 months 05-2026: 0.3% 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.2%▼ -0.1 percentage points vs 09-2026lowest value
Credit of up to €13,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 2.06, above the usual 1.5; short-term debt: 22.4% and cash: 0.5% of total assets), and 22.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 12% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 2.06, cash €1,062
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Size: total assets €200,760
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 31-01-2026, 0 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
on the day
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: DALLEMAGNEMaxTonyAriane (director) · Founder…

Key points

  • Founded 17 months agofounded 24-04-2025 17 months View
  • Positive: Among the best 19% on net resultsector median €60,171 · 20,545 companies €152,760 View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€200,760
Profit
€152,760
Solvency
77.6%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
24-04-2025
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure